Expression of S100A2 and Trefoil Factor Family Members in Epstein-Barr Virus Related Gastric Cancer

• Conditions: Gastric Cancer

• Registration Number: NCT01100814
• Lead Sponsor: National University Hospital, Singapore

Brief Summary

The investigators hypothesize that aberrant hypermethylation of tumour suppressor genes is an important mechanism for Epstein-Barr Virus (EBV) - related gastric carcinogenesis, the promoter hypermethylation status and the expression of S100A2 and TFF1 might be different between EBV-associated gastric cancer (GC) and non EBV-associated GC.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2009-09-15
• Study First Submitted QC: 2010-04-07
• Study First Posted: 2010-04-09
• Study Start: 2011-09
• Status Verified: 2014-01
• Last Update Submitted: 2014-01-21
• Last Update Posted: 2014-01-22
• Primary Completion: 2014-12
• Study Completion: 2014-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Nil

Exclusion Criteria

• Nil

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

National University Hospital; 🇸🇬 Singapore, Singapore